Geisinger Health System

Haymarket Medical Education and myCME, in Partnership With Sleep-Wake Advisor, Announce Launch of the Sleep-Wake Advisor Institute

Retrieved on: 
Wednesday, February 21, 2024
Sports, General Sports, Education, Health, General Health, Other Science, Training, Research, Science, Other Education, Continuing, Geisinger Health System, Advisory board, HME, Geisinger Medical Center, Medical education, News, Quality of life, Hospital, Sleep, Neurology, Perception, Faculty, University, Jools' Annual Hootenanny, Patient, University of California, Knowledge, Medical school, Pharmaceutical industry

“Today is an exciting day in the field of Sleep-Wake medicine,” said Jacqui Brooks, MBBCh, MRCPsych, Vice President, Medical Strategy at Haymarket Medical Education.

Key Points: 
  • “Today is an exciting day in the field of Sleep-Wake medicine,” said Jacqui Brooks, MBBCh, MRCPsych, Vice President, Medical Strategy at Haymarket Medical Education.
  • “The launch of the Sleep-Wake Advisor Institute demonstrates Haymarket’s commitment to sleep medicine and its impact across medicine, and will provide a long-needed, one-of-a-kind resource for sleep-wake clinicians.
  • This year will also see the launch of Sleep-Wake Advisor in Spring 2024 and our Sleep-Wake Advisor Summit in June.”
    “Sleep-Wake Advisor Institute is more than an educational platform.
  • To learn more and become part of the Sleep-Wake Advisor Institute community, CLICK HERE .

Zimmer Biomet Announces Appointment of Louis A. Shapiro to Board of Directors

Retrieved on: 
Friday, January 5, 2024
Quality of life, Hospital, Science, Geisinger Health System, Pain, McKinsey & Company, HSS, University, Elective surgery, Patient, Public health, News, Newsweek, Management

WARSAW, Ind., Jan. 5, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Louis A. Shapiro, formerly the President and Chief Executive Officer of the Hospital for Special Surgery (HSS), has been appointed to the Board, effective immediately.

Key Points: 
  • WARSAW, Ind., Jan. 5, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global medical technology leader, today announced that Louis A. Shapiro, formerly the President and Chief Executive Officer of the Hospital for Special Surgery (HSS), has been appointed to the Board, effective immediately.
  • "We look forward to Lou's contributions as we continue to advance our mission together."
  • Mr. Shapiro joined HSS as its President and Chief Executive Officer in October 2006, retiring in October 2023.
  • Mr. Shapiro has a bachelor of science degree in psychology from the University of Pittsburgh and a master's degree in health administration from the University of Pittsburgh Graduate School of Public Health.

Tomorrow Health and Geisinger Health Plan Release New Data Demonstrating Improved Home-Based Care Delivery

Retrieved on: 
Wednesday, November 1, 2023
Health, GHP, D.O, MBA, Geisinger Health System, ROI, Quality of life, Caregiver, Overalls, Patient, Nursing

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Tomorrow Health, the leading home-based healthcare platform, recently released new data with Geisinger Health Plan (GHP), illustrating how improving home-based care delivery can have measurable impacts on health plan costs, member satisfaction, and overall health outcomes for patients.

Key Points: 
  • Tomorrow Health technology platform drove 4x ROI, 95% member satisfaction
    NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Tomorrow Health , the leading home-based healthcare platform, recently released new data with Geisinger Health Plan (GHP), illustrating how improving home-based care delivery can have measurable impacts on health plan costs, member satisfaction, and overall health outcomes for patients.
  • "Tomorrow Health's transformative approach to home-based care has streamlined the entire process for our providers, suppliers, and patients," said Dr. John Bulger, D.O., MBA, chief medical officer at Geisinger Health Plan.
  • However, when Tomorrow Health began working with the health plan in 2021, Geisinger was having challenges delivering home-based care for its members, which resulted in costly operations and an unpredictable care experience for patients and their caregivers.
  • To learn more about Tomorrow Health and Geisinger Health Plan's work together, download a copy of "The Current State of Home-Based Care" here .

HARMONY BIOSCIENCES SHOWCASES THE NEWEST PATIENTS AT THE HEART AND PROGRESS AT THE HEART AWARD RECIPIENTS

Retrieved on: 
Thursday, October 26, 2023
DSM-IV codes, Patient, DO, Sleep, Heart, Sleep disorder, Historically black colleges and universities, Education, Prader–Willi syndrome, Health, Life, Corporate Affairs, Organization, Kleine–Levin syndrome, Rare, Progress, Neurological disorder, Communes of Burundi, Caregiver, Harmony, Student, Interim, MS, University, Geisinger Health System, PWS, Diagnosis, Empathy, KLS, Pharmaceutical industry, Residential care, Nursing

"With support from a previous Patients at the Heart award, we achieved the 'Strategic Communications for Awareness' project, which fortified and expanded our patient registry and outreach endeavors.

Key Points: 
  • "With support from a previous Patients at the Heart award, we achieved the 'Strategic Communications for Awareness' project, which fortified and expanded our patient registry and outreach endeavors.
  • Progress at the Heart provides funding support for novel initiatives addressing disparities, injustices, and inequities in rare neurological disease and sleep disorder communities.
  • The next call for Patients at the Heart and Progress at the Heart award nominations will be announced next year.
  • To learn more about Patients at the Heart, please visit: https://www.harmonybiosciences.com/funding-programs/patients-at-the-heart/ .

Liquid Biopsy Market size is set to grow by USD 1.74 billion from 2021 to 2026 | The Increasing incidence of cancer drives the market growth - Technavio

Retrieved on: 
Tuesday, October 24, 2023
Neoplasm, OME Care, Laboratory, Abdominal ultrasonography, Incidence, Liquid biopsy, Johns Hopkins University, RNA, Biotechnology, GRAIL, ROW, Prevalence, Disease, Developed country, Chinese, R, Helmy Eltoukhy, World Games, Growth, Life expectancy, Methylation, Risk, Exosome, Cancer, Biopsy, Hospital, Breast cancer, Geisinger Health System, USD, Needle, Patient, Diagnosis, Bias, CTC, DNA, Medical imaging, Geography, COVID-19

NEW YORK, Oct. 24, 2023 /PRNewswire/ -- The liquid biopsy market size is estimated to grow by USD 1.74 billion from 2021 to 2026, according to Technavio.

Key Points: 
  • NEW YORK, Oct. 24, 2023 /PRNewswire/ -- The liquid biopsy market size is estimated to grow by USD 1.74 billion from 2021 to 2026, according to Technavio.
  • The growing incidence of cancers will subsequently increase the diagnosis using the liquid biopsy method, expected to drive the market growth during the forecast period.
  • The increasing funding/investment for fluid biopsy is a liquid biopsy market trend that is expected to drive market growth.
  • Growth of the liquid biopsy market across North America, Europe, Asia, and ROW
    Gain instant access to 17,000+ market research reports.

HHP and Hydra Health team up to expand amenities in hospitals and health systems nationwide

Retrieved on: 
Wednesday, September 13, 2023
Lactation, University of Pennsylvania Health System, Goldman Sachs, Operation, Restaurant, Cancer, Partnership, Hospital, Geisinger Health System, Harry Kloor, Patient, Geisinger, Pharmaceutical industry, HHP

HHP (Health Hospitality Partners) has acquired a majority stake in Hydra Health, allowing them to deepen their partnership and expand into new markets.

Key Points: 
  • HHP (Health Hospitality Partners) has acquired a majority stake in Hydra Health, allowing them to deepen their partnership and expand into new markets.
  • HHP and Hydra Health partnered to open the first Hydra Health studio at Geisinger's Henry Cancer Center in 2022.
  • Hydra Health co-founder and CEO Marie Kloor will now serve as Vice President, Operations & Development at HHP.
  • Kloor began her career in investment management at Goldman Sachs before launching Hydra Health.

Guardant Health Receives Coverage for Guardant Reveal™ from Geisinger Health Plan

Retrieved on: 
Wednesday, September 6, 2023
Vitamins, Supplements, Insurance, Health Technology, Professional Services, Biotechnology, Managed Care, Health, General Health, Oncology, Survivor, DNA, Policy, Cancer, Geisinger Health System, National Comprehensive Cancer Network, GH, MRD, Medicare, Helmy Eltoukhy, Journal of the National Comprehensive Cancer Network, HIV disease progression rates, Patient, Colorectal cancer, Blood, Neoplasm, Recurrence, III, Disease, Pharmaceutical industry

Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced today that Geisinger Health Plan now offers coverage for the Guardant Reveal™ minimal residual disease (MRD) test.

Key Points: 
  • Guardant Health, Inc. (NASDAQ:GH), a leading precision oncology company, announced today that Geisinger Health Plan now offers coverage for the Guardant Reveal™ minimal residual disease (MRD) test.
  • “We are pleased that Geisinger Health Plan has taken this important step to make blood testing for residual disease more accessible to its members,” said Helmy Eltoukhy, Guardant Health chairman and co-CEO.
  • The Geisinger Health Plan provides coverage for more than half a million members.
  • This policy decision adds to the payor coverage of Guardant Reveal, which received Medicare coverage in August 2022 and additional commercial payor coverage in July 2023.

Healthcare M&A Volume Jumps in Q2:23, According to Acquisition Data from LevinPro HC

Retrieved on: 
Thursday, July 20, 2023
Hospice, Housing, Health & Other Services Personnel Trade Union of South Africa, Kaiser Permanente, Intelligence, Research, Hospital, Acquisition, EHealth, Patient, Physician, Health care, HC, Geisinger Health System, Pharmaceutical industry, EBITDA

NEW CANAAN, Conn., July 20, 2023 /PRNewswire-PRWeb/ -- Health care merger and acquisition activity increased nearly 10% in the second quarter of 2023, hitting 696 deals, according to new acquisition data from LevinPro HC. Activity in the second quarter was 8% higher than in the first quarter, when 646 transactions were announced. However, it is a drop of 7% compared with activity in the second quarter of 2022, when 748 deals were announced.

Key Points: 
  • Health care merger and acquisition activity increased nearly 10% in the second quarter of 2023, hitting 696 deals, according to new acquisition data from LevinPro HC.
  • NEW CANAAN, Conn., July 20, 2023 /PRNewswire-PRWeb/ -- Health care merger and acquisition activity increased nearly 10% in the second quarter of 2023, hitting 696 deals, according to new acquisition data from LevinPro HC.
  • However, it is a drop of 7% compared with activity in the second quarter of 2022, when 748 deals were announced.
  • Demand for healthcare real estate, such as medical office buildings and properties, has driven high deal volume in the Other Services for the past several years.

Digital Care Management Improves MSK Care, Force Therapeutics Report Shows

Retrieved on: 
Tuesday, July 18, 2023
Pros, CMS, ODI, Hip, Shoulder, Centers for Medicare & Medicaid Services, Disability, VBC, Center for Medicare and Medicaid Innovation, Element, ASES, MCID, Pain, Medicare, Hospital, Patient, Collection, Length of stay, KOOS, Force, MSK, BBC, Geisinger Health System, FFS, Therapy, SCB, Mental health, Knee, Medical device, Nursing, Pharmaceutical industry, Health insurance, Birth control

NEW YORK, July 18, 2023 /PRNewswire/ -- Force Therapeutics, the leading musculoskeletal (MSK) digital care management platform, announced today the release of a new report demonstrating that its virtual care management and remote engagement platform resulted in clinically significant improvements in patient-reported outcomes (PROs) including pain, function, mental health, and activities of daily living in MSK patients.

Key Points: 
  • Upcoming CMS incentives require providers to drive high-quality, value-based care through stronger patient engagement and care pathway compliance
    NEW YORK, July 18, 2023 /PRNewswire/ -- Force Therapeutics, the leading musculoskeletal (MSK) digital care management platform, announced today the release of a new report demonstrating that its virtual care management and remote engagement platform resulted in clinically significant improvements in patient-reported outcomes (PROs) including pain, function, mental health, and activities of daily living in MSK patients.
  • 90% of patients reported being "satisfied" or "very satisfied" with their surgical episodes combined with Force Therapeutics' care management plans.
  • "Providers must be prepared for the increasingly rigorous requirements surrounding care quality and outcomes, which necessitate the implementation of holistic digital and remote care solutions," said Bronwyn Spira, CEO and founder, Force Therapeutics.
  • "Without a comprehensive digital care strategy and strong patient engagement, providers will find it difficult to succeed in the rapidly evolving MSK care landscape," said Mark Lieberman, President and co-founder, Force Therapeutics.

New Book Features Walmart's History in Healthcare - From $4 Prescriptions to Today's Walmart Health 'Super Centers'

Retrieved on: 
Wednesday, June 14, 2023
Giant, Workforce, Heart, Cleveland Clinic, Mayo Clinic, Center of excellence, Cancer, Geisinger Health System, Second opinion, Attention, Congress, Giant Eagle, Walmart, Mental, Clinical professor, Grocery store, Pharmaceutical industry, Health insurance

WOBURN, Mass., June 14, 2023 /PRNewswire-PRWeb/ -- As retailers rush to fill their stores with medical services, Walmart's three-decade history in healthcare from Sam Walton's vision to control costs to today's doctor-staffed Walmart Health "super centers" are featured in a new book: "Walmart's Second Opinion."

Key Points: 
  • "This book outlines not only Walmart's history as a provider and payer of healthcare services, but the kind of progress Sam Walton wanted to see when he approached Tom Emerick in 1991 for ideas on how to control costs while improving quality for employees."
  • Though Walmart is best known for its prowess as a big box retailer offering everything from general merchandise to groceries, its healthcare services and benefits for employees have become models and copied across the country.
  • These days, Walmart is expanding mental health services for employees and customers while adding behavioral care to the dental services and outpatient primary care at its Walmart Health brand centers that treat consumers across the country.
  • Such facilities are projected to double by the end of 2024.